{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:56:33Z","timestamp":1793706993465,"version":"4.6.1"},"reference-count":182,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"DOI":"10.1007\/s00726-025-03454-5","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T07:25:22Z","timestamp":1746689122000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Therapeutic peptides: chemical strategies fortify peptides for enhanced disease treatment efficacy"],"prefix":"10.1007","volume":"57","author":[{"given":"Qingmei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"issue":"11","key":"3454_CR1","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3390\/biom11111716","volume":"11","author":"M Abdulbagi","year":"2021","unstructured":"Abdulbagi M, Wang LY, Siddig O, Di B, Li B (2021) D-amino acids and D-amino acid-containing peptides: potential disease biomarkers and therapeutic targets? Biomolecules 11(11):242\u2013253. https:\/\/doi.org\/10.3390\/biom11111716","journal-title":"Biomolecules"},{"issue":"7","key":"3454_CR2","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1021\/acschembio.9b00234","volume":"14","author":"E Adaligil","year":"2019","unstructured":"Adaligil E, Patil K, Rodenstein M, Kumar K (2019) Discovery of peptide antibiotics composed of D-amino acids. ACS Chem Biol 14(7):1498\u20131506. https:\/\/doi.org\/10.1021\/acschembio.9b00234","journal-title":"ACS Chem Biol"},{"issue":"12","key":"3454_CR3","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1021\/ml300148v","volume":"3","author":"HB Albada","year":"2012","unstructured":"Albada HB, Prochnow P, Bobersky S, Langklotz S, Schriek P, Bandow JE, Metzler-Nolte N (2012) Tuning the activity of a short arg-trp antimicrobial peptide by lipidation of a c- or n-terminal lysine side-chain. ACS Med Chem Lett 3(12):980\u2013984. https:\/\/doi.org\/10.1021\/ml300148v","journal-title":"ACS Med Chem Lett"},{"issue":"6","key":"3454_CR5","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1039\/c7sc04383j","volume":"9","author":"Z Amso","year":"2018","unstructured":"Amso Z, Bisset SW, Yang SH, Harris PWR, Wright TH, Navo CD, Patchett ML, Norris GE, Brimble MA (2018) Total chemical synthesis of glycocin F and analogues: S-glycosylation confers improved antimicrobial activity. Chem Sci 9(6):1686\u20131691. https:\/\/doi.org\/10.1039\/c7sc04383j","journal-title":"Chem Sci"},{"issue":"6","key":"3454_CR6","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.bbamem.2018.03.021","volume":"1860","author":"K Andreev","year":"2018","unstructured":"Andreev K, Martynowycz MW, Huang ML, Kuzmenko I, Bu W, Kirshenbaum K, Gidalevitz D (2018) Hydrophobic interactions modulate antimicrobial peptoid selectivity towards anionic lipid membranes. Biochim Biophys Acta Biomembr 1860(6):1414\u20131423. https:\/\/doi.org\/10.1016\/j.bbamem.2018.03.021","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"9","key":"3454_CR7","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1002\/anie.201906908","volume":"59","author":"V Armiento","year":"2020","unstructured":"Armiento V, Spanopoulou A, Kapurniotu A (2020) Peptide-based molecular strategies to interfere with protein misfolding, aggregation, and cell degeneration. Angew Chem Int Ed 59(9):3372\u20133384. https:\/\/doi.org\/10.1002\/anie.201906908","journal-title":"Angew Chem Int Ed"},{"issue":"1","key":"3454_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00726-024-03397-3","volume":"56","author":"A Aslan","year":"2024","unstructured":"Aslan A, Yuka SA (2024) Therapeutic peptides for coronary artery diseases: in silico methods and current perspectives. Amino Acids 56(1):241\u2013253. https:\/\/doi.org\/10.1007\/s00726-024-03397-3","journal-title":"Amino Acids"},{"issue":"3","key":"3454_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fimmu.2021.637963","volume":"12","author":"A Azam","year":"2021","unstructured":"Azam A, Mallart S, Illiano S, Duclos O, Prades C, Maill\u00e8re B (2021) Introduction of non-natural amino acids into t-cell epitopes to mitigate peptide-specific t-cell responses. Front Immunol 12(3):12\u201320. https:\/\/doi.org\/10.3389\/fimmu.2021.637963","journal-title":"Front Immunol"},{"issue":"22","key":"3454_CR10","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.2217\/nnm.15.137","volume":"10","author":"F Azmi","year":"2015","unstructured":"Azmi F, Elliott AG, Khalil ZG, Hussein WM, Kavanagh A, Huang JX, Quezada M, Blaskovich MAT, Capon RJ, Cooper MA, Skwarczynski M, Toth I (2015) Self-assembling lipopeptides with a potent activity against gram-positive bacteria, including multidrug resistant strains. Nanomed Nanotechnol 10(22):3359\u20133371. https:\/\/doi.org\/10.2217\/nnm.15.137","journal-title":"Nanomed Nanotechnol"},{"issue":"10","key":"3454_CR11","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1016\/j.bmc.2016.03.053","volume":"24","author":"F Azmi","year":"2016","unstructured":"Azmi F, Elliott AG, Marasini N, Ramu S, Ziora Z, Kavanagh AM, Blaskovich MAT, Cooper MA, Skwarczynski M, Toth I (2016) Short cationic lipopeptides as effective antibacterial agents: design, physicochemical properties and biological evaluation. Bioorgan Med Chem 24(10):2235\u20132241. https:\/\/doi.org\/10.1016\/j.bmc.2016.03.053","journal-title":"Bioorgan Med Chem"},{"issue":"32","key":"3454_CR12","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.carbpol.2017.02.050","volume":"165","author":"M Barbosa","year":"2017","unstructured":"Barbosa M, Vale N, Costa FMTA, Martins MCL, Gomes P (2017) Tethering antimicrobial peptides onto chitosan: optimization of azide-alkyne \u201cclick\u201d reaction conditions. Carbohydr Polym 165(32):384\u2013393. https:\/\/doi.org\/10.1016\/j.carbpol.2017.02.050","journal-title":"Carbohydr Polym"},{"issue":"3","key":"3454_CR14","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1177\/0022034516679973","volume":"96","author":"B Bechinger","year":"2017","unstructured":"Bechinger B, Gorr SU (2017) Antimicrobial peptides: mechanisms of action and resistance. J Dent Res 96(3):254\u2013260. https:\/\/doi.org\/10.1177\/0022034516679973","journal-title":"J Dent Res"},{"issue":"2","key":"3454_CR15","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3389\/fmicb.2018.01048","volume":"9","author":"F B\u00e9dard","year":"2018","unstructured":"B\u00e9dard F, Biron E (2018) Recent progress in the chemical synthesis of class ii and s-glycosylated bacteriocins. Front Microbiol 9(2):214\u2013222. https:\/\/doi.org\/10.3389\/fmicb.2018.01048","journal-title":"Front Microbiol"},{"issue":"6","key":"3454_CR16","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.drudis.2017.02.001","volume":"22","author":"NG Bednarska","year":"2017","unstructured":"Bednarska NG, Wren BW, Willcocks SJ (2017) The importance of the glycosylation of antimicrobial peptides: natural and synthetic approaches. Drug Discov Today 22(6):919\u2013926. https:\/\/doi.org\/10.1016\/j.drudis.2017.02.001","journal-title":"Drug Discov Today"},{"issue":"1","key":"3454_CR17","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1128\/Aac.01923-12","volume":"57","author":"N Berthold","year":"2013","unstructured":"Berthold N, Czihal P, Fritsche S, Sauer U, Schiffer G, Knappe D, Alber G, Hoffmann R (2013) Novel apidaecin 1b analogs with superior serum stabilities for treatment of infections by gram-negative pathogens. Antimicrob Agents Chemother 57(1):402\u2013409. https:\/\/doi.org\/10.1128\/Aac.01923-12","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"3454_CR18","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1021\/acschembio.8b00055","volume":"13","author":"SW Bisset","year":"2018","unstructured":"Bisset SW, Yang SH, Amso Z, Harris PWR, Patchett ML, Brimble MA, Norris GE (2018) Using chemical synthesis to probe structure-activity relationships of the glycoactive bacteriocin glycocin F. ACS Chem Biol 13(5):1270\u20131278. https:\/\/doi.org\/10.1021\/acschembio.8b00055","journal-title":"ACS Chem Biol"},{"issue":"8","key":"3454_CR19","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1021\/acsinfecdis.1c00157","volume":"7","author":"S Biswas","year":"2021","unstructured":"Biswas S, Wu CY, van der Donk WA (2021) The antimicrobial activity of the glycocin sublancin is dependent on an active phosphoenolpyruvate-sugar phosphotransferase system. ACS Infect Dis 7(8):2402\u20132412. https:\/\/doi.org\/10.1021\/acsinfecdis.1c00157","journal-title":"ACS Infect Dis"},{"issue":"40","key":"3454_CR20","doi-asserted-by":"publisher","first-page":"6622","DOI":"10.1002\/anie.200600855","volume":"45","author":"L Brunsveld","year":"2006","unstructured":"Brunsveld L, Kuhlmann J, Alexandrov K, Wittinghofer A, Goody RS, Waldmann H (2006) Lipidated ras and rab peptides and proteins\u2014synthesis, structure, and function. Angew Chem Int Ed 45(40):6622\u20136646. https:\/\/doi.org\/10.1002\/anie.200600855","journal-title":"Angew Chem Int Ed"},{"issue":"5","key":"3454_CR21","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1002\/chem.201905385","volume":"27","author":"LK Buckton","year":"2021","unstructured":"Buckton LK, Rahimi MN, McAlpine SR (2021) Cyclic peptides as drugs for intracellular targets: the next frontier in peptide therapeutic development. Chem Eur J 27(5):1487\u20131513. https:\/\/doi.org\/10.1002\/chem.201905385","journal-title":"Chem Eur J"},{"issue":"8","key":"3454_CR24","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/antibiotics9080451","volume":"9","author":"YY Cai","year":"2020","unstructured":"Cai YY, Leck H, Tan RW, Teo JQ, Lim TP, Lee WN, Chlebicki MP, Kwa AL (2020) Clinical experience with high-dose polymyxin b against carbapenem-resistant gram-negative bacterial infections\u2014a cohort study. Antibiot Basel 9(8):234\u2013245. https:\/\/doi.org\/10.3390\/antibiotics9080451","journal-title":"Antibiot Basel"},{"issue":"23","key":"3454_CR25","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/bs.apcsb.2018.01.008","volume":"112","author":"MH Cardoso","year":"2018","unstructured":"Cardoso MH, Oshiro KGN, Rezende SB, C\u00e2ndido ES, Franco OL (2018) The structure\/function relationship in antimicrobial peptides: what can we obtain from structural data? Adv Protein Chem Struct 112(23):359\u2013384. https:\/\/doi.org\/10.1016\/bs.apcsb.2018.01.008","journal-title":"Adv Protein Chem Struct"},{"issue":"18","key":"3454_CR27","doi-asserted-by":"publisher","first-page":"12002","DOI":"10.1021\/acs.jmedchem.2c00539","volume":"65","author":"K Cheng","year":"2022","unstructured":"Cheng K, Fetse J, Zhao Z, Liu H, Mamani UF, Mustafa B, Adhikary P, Ibrahim M, Liu YL, Patel P, Nakhjiri M, Alahmari M, Li GF (2022) Discovery of cyclic peptide inhibitors targeting PD-L1 for cancer immunotherapy. J Med Chem 65(18):12002\u201312013. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c00539","journal-title":"J Med Chem"},{"issue":"1","key":"3454_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4062\/biomolther.2019.082","volume":"28","author":"JS Choi","year":"2020","unstructured":"Choi JS, Joo SH (2020) Recent trends in cyclic peptides as therapeutic agents and biochemical tools. Biomol Ther 28(1):18\u201324. https:\/\/doi.org\/10.4062\/biomolther.2019.082","journal-title":"Biomol Ther"},{"issue":"3","key":"3454_CR29","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ejpb.2008.09.025","volume":"71","author":"DA Christian","year":"2009","unstructured":"Christian DA, Cai S, Bowen DM, Kim Y, Pajerowski JD, Discher DE (2009) Polymersome carriers: from self-assembly to siRNA and protein therapeutics. Eur J Pharm Biopharm 71(3):463\u2013474. https:\/\/doi.org\/10.1016\/j.ejpb.2008.09.025","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"3454_CR30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/med.21321","volume":"36","author":"SA Cochrane","year":"2016","unstructured":"Cochrane SA, Vederas JC (2016) Lipopeptides from Bacillus and Paenibacillus spp.: a gold mine of antibiotic candidates. Med Res Rev 36(1):4\u201331. https:\/\/doi.org\/10.1002\/med.21321","journal-title":"Med Res Rev"},{"issue":"10","key":"3454_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.drudis.2023.103714","volume":"28","author":"AS De Groot","year":"2023","unstructured":"De Groot AS, Roberts BJ, Mattei A, Lelias S, Boyle C, Martin W (2023) Immunogenicity risk assessment of synthetic peptide drugs and their impurities. Drug Discov Today 28(10):11\u201320. https:\/\/doi.org\/10.1016\/j.drudis.2023.103714","journal-title":"Drug Discov Today"},{"issue":"27","key":"3454_CR35","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1021\/acs.biochem.7b00268","volume":"56","author":"CA De Leon","year":"2017","unstructured":"De Leon CA, Levine PM, Craven TW, Pratt MR (2017) The sulfur-linked analogue of O-GlcNAc (S-GlcNAc) is an enzymatically stable and reasonable structural surrogate for O-GlcNAc at the peptide and protein levels. Biochemistry 56(27):3507\u20133517. https:\/\/doi.org\/10.1021\/acs.biochem.7b00268","journal-title":"Biochemistry"},{"issue":"16","key":"3454_CR36","doi-asserted-by":"publisher","first-page":"5032","DOI":"10.1021\/acs.orglett.8b02182","volume":"20","author":"CA De Leon","year":"2018","unstructured":"De Leon CA, Lang G, Saavedra MI, Pratt MR (2018) Simple and efficient preparation of O- and S-GlcNAcylated amino acids through InBr(3)-catalyzed synthesis of beta-N-acetylglycosides from commercially available reagents. Org Lett 20(16):5032\u20135035. https:\/\/doi.org\/10.1021\/acs.orglett.8b02182","journal-title":"Org Lett"},{"issue":"5","key":"3454_CR37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1371\/journal.ppat.1004152","volume":"10","author":"C de la Fuente-N\u00fa\u00f1ez","year":"2014","unstructured":"de la Fuente-N\u00fa\u00f1ez C, Reffuveille F, Haney EF, Straus SK, Hancock REW (2014) Broad-Spectrum anti-biofilm peptide that targets a cellular stress response. PLoS Pathog 10(5):23\u201332. https:\/\/doi.org\/10.1371\/journal.ppat.1004152","journal-title":"PLoS Pathog"},{"issue":"32","key":"3454_CR38","doi-asserted-by":"publisher","first-page":"4020492","DOI":"10.1155\/2018\/4020492","volume":"2018","author":"MI Del Olmo-Garcia","year":"2018","unstructured":"Del Olmo-Garcia MI, Merino-Torres JF (2018) GLP-1 receptor agonists and cardiovascular disease in patients with type 2 diabetes. J Diabetes Res 2018(32):4020492\u20134020498. https:\/\/doi.org\/10.1155\/2018\/4020492","journal-title":"J Diabetes Res"},{"issue":"16","key":"3454_CR40","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3390\/molecules24162987","volume":"24","author":"C Domhan","year":"2019","unstructured":"Domhan C, Uhl P, Kleist C, Zimmermann S, Umstatter F, Leotta K, Mier W, Wink M (2019) Replacement of l-amino acids by d-amino acids in the antimicrobial peptide ranalexin and its consequences for antimicrobial activity and biodistribution. Molecules 24(16):324\u2013333. https:\/\/doi.org\/10.3390\/molecules24162987","journal-title":"Molecules"},{"issue":"19","key":"3454_CR41","doi-asserted-by":"publisher","first-page":"5145","DOI":"10.1021\/acs.langmuir.0c00282","volume":"36","author":"TM Domingues","year":"2020","unstructured":"Domingues TM, Perez KR, Riske KA (2020) Revealing the mode of action of halictine antimicrobial peptides: a comprehensive study with model membranes. Langmuir 36(19):5145\u20135155. https:\/\/doi.org\/10.1021\/acs.langmuir.0c00282","journal-title":"Langmuir"},{"issue":"22","key":"3454_CR42","doi-asserted-by":"publisher","first-page":"10098","DOI":"10.1021\/acs.jmedchem.9b00456","volume":"62","author":"PG Dougherty","year":"2019","unstructured":"Dougherty PG, Wen J, Pan XY, Koley A, Ren JG, Sahni A, Basu R, Salim H, Kubi GA, Qian ZQ, Pei DH (2019) Enhancing the cell permeability of stapled peptides with a cyclic cell-penetrating peptide. J Med Chem 62(22):10098\u201310107. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b00456","journal-title":"J Med Chem"},{"issue":"10","key":"3454_CR43","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s00726-019-02779-2","volume":"51","author":"R Dwivedi","year":"2019","unstructured":"Dwivedi R, Aggarwal P, Bhavesh NS, Kaur KJ (2019) Design of therapeutically improved analogue of the antimicrobial peptide, indolicidin, using a glycosylation strategy. Amino Acids 51(10):1443\u20131460. https:\/\/doi.org\/10.1007\/s00726-019-02779-2","journal-title":"Amino Acids"},{"issue":"5881","key":"3454_CR44","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/299371a0","volume":"299","author":"D Eisenberg","year":"1982","unstructured":"Eisenberg D, Weiss RM, Terwilliger TC (1982) The helical hydrophobic moment: a measure of the amphiphilicity of a helix. Nature 299(5881):371\u2013374. https:\/\/doi.org\/10.1038\/299371a0","journal-title":"Nature"},{"issue":"17","key":"3454_CR46","doi-asserted-by":"publisher","first-page":"9228","DOI":"10.1021\/acs.jmedchem.0c00303","volume":"63","author":"H Etayash","year":"2020","unstructured":"Etayash H, Pletzer D, Kumar P, Straus SK, Hancock REW (2020) Cyclic derivative of host-defense peptide IDR-1018 improves proteolytic stability, suppresses inflammation, and enhances in vivo activity. J Med Chem 63(17):9228\u20139236. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00303","journal-title":"J Med Chem"},{"issue":"7","key":"3454_CR47","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.tips.2023.04.003","volume":"44","author":"J Fetse","year":"2023","unstructured":"Fetse J, Kandel S, Mamani UF, Cheng K (2023) Recent advances in the development of therapeutic peptides. Trends Pharmacol Sci 44(7):425\u2013441. https:\/\/doi.org\/10.1016\/j.tips.2023.04.003","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"3454_CR48","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","volume":"20","author":"K Fosgerau","year":"2015","unstructured":"Fosgerau K, Hoffmann T (2015) Peptide therapeutics: current status and future directions. Drug Discov Today 20(1):122\u2013128. https:\/\/doi.org\/10.1016\/j.drudis.2014.10.003","journal-title":"Drug Discov Today"},{"issue":"2","key":"3454_CR49","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s40265-023-01992-4","volume":"84","author":"NL France","year":"2024","unstructured":"France NL, Syed YY (2024) Tirzepatide: a review in type 2 diabetes. Drugs 84(2):227\u2013238. https:\/\/doi.org\/10.1007\/s40265-023-01992-4","journal-title":"Drugs"},{"issue":"13","key":"3454_CR53","doi-asserted-by":"publisher","first-page":"7820","DOI":"10.1039\/d0cs00729c","volume":"50","author":"BH Gan","year":"2021","unstructured":"Gan BH, Gaynord J, Rowe SM, Deingruber T, Spring DR (2021) The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions. Chem Soc Rev 50(13):7820\u20137880. https:\/\/doi.org\/10.1039\/d0cs00729c","journal-title":"Chem Soc Rev"},{"issue":"2","key":"3454_CR1000","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1039\/d1cs90109e","volume":"51","author":"BH Gan","year":"2022","unstructured":"Gan BH, Gaynord J, Rowe SM, Deingruber T, Spring DR (2022) The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions. Chem Soc Rev 51(2):792\u2013820. https:\/\/doi.org\/10.1039\/d1cs90109e","journal-title":"Chem Soc Rev"},{"issue":"1","key":"3454_CR54","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/btm2.10600","volume":"9","author":"YS Gao","year":"2024","unstructured":"Gao YS, Joshi M, Zhao ZM, Mitragotri S (2024) PEGylated therapeutics in the clinic. Bioeng Transl Med 9(1):23\u201334. https:\/\/doi.org\/10.1002\/btm2.10600","journal-title":"Bioeng Transl Med"},{"issue":"23\u201324","key":"3454_CR55","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.1002\/pmic.200800295","volume":"8","author":"S Gauci","year":"2008","unstructured":"Gauci S, van Breukelen B, Lemeer SM, Krijgsveld J, Heck AJ (2008) A versatile peptide pi calculator for phosphorylated and n-terminal acetylated peptides experimentally tested using peptide isoelectric focusing. Proteomics 8(23\u201324):4898\u20134906. https:\/\/doi.org\/10.1002\/pmic.200800295","journal-title":"Proteomics"},{"issue":"1","key":"3454_CR57","doi-asserted-by":"publisher","first-page":"147","DOI":"10.5661\/bger-28-147","volume":"28","author":"D Ghaderi","year":"2012","unstructured":"Ghaderi D, Zhang M, Hurtado-Ziola N, Varki A (2012) Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation. Biotechnol Genet Eng 28(1):147\u2013175. https:\/\/doi.org\/10.5661\/bger-28-147","journal-title":"Biotechnol Genet Eng"},{"issue":"3","key":"3454_CR58","doi-asserted-by":"publisher","first-page":"1310443","DOI":"10.3389\/fimmu.2024.1310443","volume":"15","author":"N Ghadiri","year":"2024","unstructured":"Ghadiri N, Javidan M, Sheikhi S, Tastan O, Parodi A, Liao Z, Tayybi Azar M, Ganjalikhani-Hakemi M (2024) Bioactive peptides: an alternative therapeutic approach for cancer management. Front Immunol 15(3):1310443\u20131310455. https:\/\/doi.org\/10.3389\/fimmu.2024.1310443","journal-title":"Front Immunol"},{"issue":"8","key":"3454_CR59","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.2174\/0113892010194428231017051836","volume":"25","author":"NH Goki","year":"2024","unstructured":"Goki NH, Tehranizadeh ZA, Saberi MR, Khameneh B, Bazzaz BSF (2024) Structure, function, and physicochemical properties of pore-forming antimicrobial peptides. Curr Pharm Biotechnol 25(8):1041\u20131057. https:\/\/doi.org\/10.2174\/0113892010194428231017051836","journal-title":"Curr Pharm Biotechnol"},{"issue":"2","key":"3454_CR60","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.biotechadv.2018.01.004","volume":"36","author":"B Gomes","year":"2018","unstructured":"Gomes B, Augusto MT, Felicio MR, Hollmann A, Franco OL, Goncalves S, Santos NC (2018) Designing improved active peptides for therapeutic approaches against infectious diseases. Biotechnol Adv 36(2):415\u2013429. https:\/\/doi.org\/10.1016\/j.biotechadv.2018.01.004","journal-title":"Biotechnol Adv"},{"issue":"8","key":"3454_CR61","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.bbamem.2008.10.009","volume":"1788","author":"LM Gottler","year":"2009","unstructured":"Gottler LM, Ramamoorthy A (2009) Structure, membrane orientation, mechanism, and function of pexiganan\u2014a highly potent antimicrobial peptide designed from magainin. Biomembranes 1788(8):1680\u20131686. https:\/\/doi.org\/10.1016\/j.bbamem.2008.10.009","journal-title":"Biomembranes"},{"issue":"33","key":"3454_CR62","doi-asserted-by":"publisher","first-page":"21359","DOI":"10.1021\/acsomega.1c01854","volume":"6","author":"S Gou","year":"2021","unstructured":"Gou S, Li B, Ouyang X, Ba Z, Zhong C, Ni J (2021) Tuning the activity of anoplin by dendrimerization of lysine and lipidation of the N-terminal. ACS Omega 6(33):21359\u201321367. https:\/\/doi.org\/10.1021\/acsomega.1c01854","journal-title":"ACS Omega"},{"issue":"14","key":"3454_CR63","doi-asserted-by":"publisher","first-page":"9401","DOI":"10.1021\/acs.jmedchem.3c00623","volume":"66","author":"V Guerlavais","year":"2023","unstructured":"Guerlavais V, Sawyer TK, Carvajal L, Chang YS, Graves B, Ren JG, Sutton D, Olson KA, Packman K, Darlak K, Elkin C, Feyfant E, Kesavan K, Gangurde P, Vassilev LT, Nash HM, Vukovic V, Aivado M, Annis DA (2023) Discovery of sulanemadlin (ALRN-6924), the first cell-permeating, stabilized \u03b1-helical peptide in clinical development. J Med Chem 66(14):9401\u20139417. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c00623","journal-title":"J Med Chem"},{"issue":"5","key":"3454_CR65","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1021\/bm500246w","volume":"15","author":"IW Hamley","year":"2014","unstructured":"Hamley IW (2014) Peg-peptide conjugates. Biomacromol 15(5):1543\u20131559. https:\/\/doi.org\/10.1021\/bm500246w","journal-title":"Biomacromol"},{"issue":"3","key":"3454_CR66","doi-asserted-by":"publisher","first-page":"21412","DOI":"10.3389\/fchem.2019.00043","volume":"7","author":"EF Haney","year":"2019","unstructured":"Haney EF, Straus SK, Hancock REW (2019) Reassessing the host defense peptide landscape. Front Chem 7(3):21412\u201321423. https:\/\/doi.org\/10.3389\/fchem.2019.00043","journal-title":"Front Chem"},{"issue":"6","key":"3454_CR67","doi-asserted-by":"publisher","first-page":"585","DOI":"10.2174\/138920309789630589","volume":"10","author":"F Harris","year":"2009","unstructured":"Harris F, Dennison SR, Phoenix DA (2009) Anionic antimicrobial peptides from eukaryotic organisms. Curr Protein Pept Sci 10(6):585\u2013606. https:\/\/doi.org\/10.2174\/138920309789630589","journal-title":"Curr Protein Pept Sci"},{"issue":"231","key":"3454_CR69","doi-asserted-by":"publisher","first-page":"757838","DOI":"10.1155\/2012\/757838","volume":"2012","author":"MA Hayashi","year":"2012","unstructured":"Hayashi MA, Ducancel F, Konno K (2012) Natural peptides with potential applications in drug development, diagnosis, and\/or biotechnology. Int J Pept 2012(231):757838\u2013757846. https:\/\/doi.org\/10.1155\/2012\/757838","journal-title":"Int J Pept"},{"issue":"1","key":"3454_CR70","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41598-024-51716-1","volume":"14","author":"S He","year":"2024","unstructured":"He S, Deber CM (2024) Interaction of designed cationic antimicrobial peptides with the outer membrane of gram-negative bacteria. Sci Rep 14(1):21\u201334. https:\/\/doi.org\/10.1038\/s41598-024-51716-1","journal-title":"Sci Rep"},{"issue":"4","key":"3454_CR71","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1021\/acs.jmedchem.7b00318","volume":"61","author":"A Henninot","year":"2018","unstructured":"Henninot A, Collins JC, Nuss JM (2018) The current state of peptide drug discovery: back to the future? J Med Chem 61(4):1382\u20131414. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b00318","journal-title":"J Med Chem"},{"issue":"3","key":"3454_CR72","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0304-4165(98)00169-X","volume":"1426","author":"R Hoffmann","year":"1999","unstructured":"Hoffmann R, Bulet P, Urge L, Otvos L (1999) Range of activity and metabolic stability of synthetic antibacterial glycopeptides from insects. BBA-Gen Subj 1426(3):459\u2013467. https:\/\/doi.org\/10.1016\/S0304-4165(98)00169-X","journal-title":"BBA-Gen Subj"},{"issue":"13","key":"3454_CR73","doi-asserted-by":"publisher","first-page":"6262","DOI":"10.1021\/acs.jmedchem.9b00566","volume":"62","author":"AJ Hone","year":"2019","unstructured":"Hone AJ, Fisher F, Christensen S, Gajewiak J, Larkin D, Whiteaker P, McIntosh JM (2019) PeiA-5466: a novel peptide antagonist containing non-natural amino acids that selectively targets \u03b13\u03b22 nicotinic acetylcholine receptors. J Med Chem 62(13):6262\u20136275. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b00566","journal-title":"J Med Chem"},{"issue":"7","key":"3454_CR74","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1021\/jm801577r","volume":"52","author":"HG Hu","year":"2009","unstructured":"Hu HG, Xue J, Swarts BM, Wang QL, Wu QY, Guo ZW (2009) Synthesis and antibacterial activities of glycosylated derivatives of tyrocidine A, a macrocyclic peptide antibiotic. J Med Chem 52(7):2052\u20132059. https:\/\/doi.org\/10.1021\/jm801577r","journal-title":"J Med Chem"},{"issue":"5","key":"3454_CR76","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.bbamem.2007.01.005","volume":"1768","author":"Y Imura","year":"2007","unstructured":"Imura Y, Nishida M, Ogawa Y, Takakura Y, Matsuzaki K (2007) Action mechanism of tachyplesin I and effects of PEGylation. Biomembranes 1768(5):1160\u20131169. https:\/\/doi.org\/10.1016\/j.bbamem.2007.01.005","journal-title":"Biomembranes"},{"issue":"3","key":"3454_CR78","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fimmu.2023.1271120","volume":"14","author":"W Jankowski","year":"2023","unstructured":"Jankowski W, Kidchob C, Bunce C, Cloake E, Resende R, Sauna ZE (2023) The MHC associated peptide proteomics assay is a useful tool for the non-clinical assessment of immunogenicity. Front Immunol 14(3):123\u2013134. https:\/\/doi.org\/10.3389\/fimmu.2023.1271120","journal-title":"Front Immunol"},{"issue":"2","key":"3454_CR79","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.eclinm.2022.101691","volume":"54","author":"LN Ji","year":"2022","unstructured":"Ji LN, Gao LL, Jiang HW, Yang J, Yu L, Wen J, Cai CH, Deng H, Feng LQ, Song BL, Ma QY, Qian L (2022) Safety and efficacy of a GLP-1 and glucagon receptor dual agonist mazdutide (IBI362) 9\u00a0mg and 10\u00a0mg in Chinese adults with overweight or obesity: a randomised, placebo-controlled, multiple-ascending-dose phase 1b trial. EClinicalMedicine 54(2):23\u201334. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101691","journal-title":"EClinicalMedicine"},{"issue":"3","key":"3454_CR80","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1021\/acs.chemrev.6b00750","volume":"118","author":"H Jiang","year":"2018","unstructured":"Jiang H, Zhang XY, Chen X, Aramsangtienchai P, Tong Z, Lin HN (2018) Protein lipidation: occurrence, mechanisms, biological functions, and enabling technologies. Chem Rev 118(3):43\u2013112. https:\/\/doi.org\/10.1021\/acs.chemrev.6b00750","journal-title":"Chem Rev"},{"issue":"23","key":"3454_CR81","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1038\/s41598-017-17234-z","volume":"8","author":"S Joshi","year":"2018","unstructured":"Joshi S, Mumtaz S, Singh J, Pasha S, Mukhopadhyay K (2018) Novel miniature membrane active lipopeptidomimetics against planktonic and biofilm embedded methicillin-resistant. Sci Rep 8(23):2324\u20132335. https:\/\/doi.org\/10.1038\/s41598-017-17234-z","journal-title":"Sci Rep"},{"issue":"8","key":"3454_CR82","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1007\/s00726-017-2441-2","volume":"49","author":"EFC Junior","year":"2017","unstructured":"Junior EFC, Guimaraes CFRC, Franco LL, Alves RJ, Kato KC, Martins HR, de Souza JD, Bemquerer MP, Munhoz VHO, Resende JM, Verly RM (2017) Glycotriazole-peptides derived from the peptide HSP1: synergistic effect of triazole and saccharide rings on the antifungal activity. Amino Acids 49(8):1389\u20131400. https:\/\/doi.org\/10.1007\/s00726-017-2441-2","journal-title":"Amino Acids"},{"issue":"12","key":"3454_CR83","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/phar.2737","volume":"42","author":"M Kelly","year":"2022","unstructured":"Kelly M, Lewis J, Rao H, Carter J, Portillo I, Beuttler R (2022) Effects of GLP-1 receptor agonists on cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease: a systematic review and meta-analysis. Pharmacotherapy 42(12):921\u2013928. https:\/\/doi.org\/10.1002\/phar.2737","journal-title":"Pharmacotherapy"},{"issue":"1","key":"3454_CR84","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1021\/acs.jmedchem.0c01536","volume":"64","author":"I Kemker","year":"2021","unstructured":"Kemker I, Schroder DC, Feiner RC, Muller KM, Marion A, Sewald N (2021) Tuning the biological activity of RGD peptides with halotryptophans. J Med Chem 64(1):586\u2013601. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c01536","journal-title":"J Med Chem"},{"issue":"5","key":"3454_CR85","doi-asserted-by":"publisher","first-page":"9143","DOI":"10.1021\/acsnano.1c02644","volume":"15","author":"M Kim","year":"2021","unstructured":"Kim M, Mun W, Jung WH, Lee J, Cho G, Kwon J, Ahn DJ, Mitchell RJ, Kim BS (2021) Antimicrobial PEGtides: a modular poly(ethylene glycol)-based peptidomimetic approach to combat bacteria. ACS Nano 15(5):9143\u20139153. https:\/\/doi.org\/10.1021\/acsnano.1c02644","journal-title":"ACS Nano"},{"issue":"23","key":"3454_CR86","doi-asserted-by":"publisher","first-page":"114322","DOI":"10.1016\/j.addr.2022.114322","volume":"186","author":"A Klepach","year":"2022","unstructured":"Klepach A, Tran H, Ahmad Mohammed F, ElSayed MEH (2022) Characterization and impact of peptide physicochemical properties on oral and subcutaneous delivery. Adv Drug Deliv Rev 186(23):114322\u2013114334. https:\/\/doi.org\/10.1016\/j.addr.2022.114322","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"3454_CR87","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3390\/biom8010004","volume":"8","author":"P Kumar","year":"2018","unstructured":"Kumar P, Kizhakkedathu JN, Straus SK (2018) Antimicrobial peptides: diversity, mechanism of action and strategies to improve the activity and biocompatibility in vivo. Biomolecules 8(1):244\u2013252. https:\/\/doi.org\/10.3390\/biom8010004","journal-title":"Biomolecules"},{"issue":"10","key":"3454_CR88","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1016\/j.bmc.2017.06.052","volume":"26","author":"JL Lau","year":"2018","unstructured":"Lau JL, Dunn MK (2018) Therapeutic peptides: historical perspectives, current development trends, and future directions. Bioorgan Med Chem 26(10):2700\u20132707. https:\/\/doi.org\/10.1016\/j.bmc.2017.06.052","journal-title":"Bioorgan Med Chem"},{"issue":"18","key":"3454_CR89","doi-asserted-by":"publisher","first-page":"7370","DOI":"10.1021\/acs.jmedchem.5b00726","volume":"58","author":"J Lau","year":"2015","unstructured":"Lau J, Bloch P, Schaffer L, Pettersson I, Spetzler J, Kofoed J, Madsen K, Knudsen LB, McGuire J, Steensgaard DB, Strauss HM, Gram DX, Knudsen SM, Nielsen FS, Thygesen P, Reedtz-Runge S, Kruse T (2015) Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide. J Med Chem 58(18):7370\u20137380. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00726","journal-title":"J Med Chem"},{"issue":"27","key":"3454_CR90","doi-asserted-by":"publisher","first-page":"8340","DOI":"10.1021\/jacs.6b03757","volume":"138","author":"G Lautrette","year":"2016","unstructured":"Lautrette G, Touti F, Lee HG, Dai P, Pentelute BL (2016) Nitrogen arylation for macrocyclization of unprotected peptides. J Am Chem Soc 138(27):8340\u20138343. https:\/\/doi.org\/10.1021\/jacs.6b03757","journal-title":"J Am Chem Soc"},{"issue":"10","key":"3454_CR92","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3390\/ijms20102383","volume":"20","author":"ACL Lee","year":"2019","unstructured":"Lee ACL, Harris JL, Khanna KK, Hong JH (2019a) A comprehensive review on current advances in peptide drug development and design. Int J Mol Sci 20(10):244\u2013256. https:\/\/doi.org\/10.3390\/ijms20102383","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3454_CR93","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bbamem.2018.10.014","volume":"1861","author":"J Lee","year":"2019","unstructured":"Lee J, Kim S, Sim JY, Lee D, Kim HH, Hwang JS, Lee DG, Park ZY, Kim JI (2019b) A potent antibacterial activity of new short D-enantiomeric lipopeptide against multi drug resistant bacteria. Biomembranes 1861(1):34\u201342. https:\/\/doi.org\/10.1016\/j.bbamem.2018.10.014","journal-title":"Biomembranes"},{"issue":"33","key":"3454_CR94","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.ejmech.2015.01.032","volume":"92","author":"DS Lele","year":"2015","unstructured":"Lele DS, Talat S, Kumari S, Srivastava N, Kaur KJ (2015) Understanding the importance of glycosylated threonine and stereospecific action of drosocin, a proline rich antimicrobial peptide. Eur J Med Chem 92(33):637\u2013647. https:\/\/doi.org\/10.1016\/j.ejmech.2015.01.032","journal-title":"Eur J Med Chem"},{"issue":"11","key":"3454_CR95","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1039\/d0cs00102c","volume":"49","author":"E Lenci","year":"2020","unstructured":"Lenci E, Trabocchi A (2020) Peptidomimetic toolbox for drug discovery. Chem Soc Rev 49(11):3262\u20133277. https:\/\/doi.org\/10.1039\/d0cs00102c","journal-title":"Chem Soc Rev"},{"issue":"30","key":"3454_CR96","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1002\/adma.201104186","volume":"24","author":"P Li","year":"2012","unstructured":"Li P, Zhou C, Rayatpisheh S, Ye K, Poon YF, Hammond PT, Duan HW, Chan-Park MB (2012) Cationic peptidopolysaccharides show excellent broad-spectrum antimicrobial activities and high selectivity. Adv Mater 24(30):4130\u20134137. https:\/\/doi.org\/10.1002\/adma.201104186","journal-title":"Adv Mater"},{"issue":"23","key":"3454_CR97","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.3389\/fnins.2017.00073","volume":"11","author":"JG Li","year":"2017","unstructured":"Li JG, Koh JJ, Liu SP, Lakshminarayanan R, Verma CS, Beuerman RW (2017) Membrane active antimicrobial peptides: translating mechanistic insights to design. Front Neurosci Switz 11(23):2321\u20132345. https:\/\/doi.org\/10.3389\/fnins.2017.00073","journal-title":"Front Neurosci Switz"},{"issue":"39","key":"3454_CR98","doi-asserted-by":"publisher","first-page":"22268","DOI":"10.1039\/c8ra03446j","volume":"8","author":"Y Li","year":"2018","unstructured":"Li Y, Wu M, Chang Q, Zhao X (2018) Stapling strategy enables improvement of antitumor activity and proteolytic stability of host-defense peptide hymenochirin-1b. RSC Adv 8(39):22268\u201322275. https:\/\/doi.org\/10.1039\/c8ra03446j","journal-title":"RSC Adv"},{"issue":"34","key":"3454_CR99","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1016\/j.jphotobiol.2019.111645","volume":"200","author":"Y Li","year":"2019","unstructured":"Li Y, Liu T, Liu Y, Tan Z, Ju Y, Yang Y, Dong WB (2019) Antimicrobial activity, membrane interaction and stability of the D-amino acid substituted analogs of antimicrobial peptide W3R6. J Photochem Photobiol B 200(34):2411\u20132443. https:\/\/doi.org\/10.1016\/j.jphotobiol.2019.111645","journal-title":"J Photochem Photobiol B"},{"issue":"2","key":"3454_CR100","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1021\/acs.jmedchem.9b01811","volume":"63","author":"CY Li","year":"2020","unstructured":"Li CY, Yap K, Swedberg JE, Craik DJ, de Veer SJ (2020a) Binding loop substitutions in the cyclic peptide SFTI-1 generate potent and selective chymase inhibitors. J Med Chem 63(2):816\u2013826. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b01811","journal-title":"J Med Chem"},{"issue":"18","key":"3454_CR101","doi-asserted-by":"publisher","first-page":"10079","DOI":"10.1021\/acs.chemrev.0c00532","volume":"120","author":"X Li","year":"2020","unstructured":"Li X, Chen S, Zhang WD, Hu HG (2020b) Stapled helical peptides bearing different anchoring residues. Chem Rev 120(18):10079\u201310144. https:\/\/doi.org\/10.1021\/acs.chemrev.0c00532","journal-title":"Chem Rev"},{"issue":"8","key":"3454_CR102","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.1039\/d0cs01026j","volume":"50","author":"W Li","year":"2021","unstructured":"Li W, Separovic F, O\u2019Brien-Simpson NM, Wade JD (2021a) Chemically modified and conjugated antimicrobial peptides against superbugs. Chem Soc Rev 50(8):4932\u20134973. https:\/\/doi.org\/10.1039\/d0cs01026j","journal-title":"Chem Soc Rev"},{"issue":"6","key":"3454_CR103","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/md19060311","volume":"19","author":"Y Li","year":"2021","unstructured":"Li Y, Li W, Xu ZS (2021bc) Improvement on permeability of cyclic peptide\/peptidomimetic: backbone-methylation as a useful tool. Mar Drugs 19(6):24\u201335. https:\/\/doi.org\/10.3390\/md19060311","journal-title":"Mar Drugs"},{"issue":"32","key":"3454_CR104","doi-asserted-by":"publisher","first-page":"107137","DOI":"10.1016\/j.phrs.2024.107137","volume":"203","author":"Y Li","year":"2024","unstructured":"Li Y, Wu M, Fu Y, Xue J, Yuan F, Qu T, Rissanou AN, Wang Y, Li X, Hu H (2024) Therapeutic stapled peptides: efficacy and molecular targets. Pharmacol Res 203(32):107137\u2013107145. https:\/\/doi.org\/10.1016\/j.phrs.2024.107137","journal-title":"Pharmacol Res"},{"issue":"24","key":"3454_CR105","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/srep14349","volume":"5","author":"ZG Liu","year":"2015","unstructured":"Liu ZG, Yu Z, Huang YY, Zhang Y, Han GZ, Li X, Dong MX, Yu S, Wang Y, Hu J, Guo HQ, Cheng YG, Lv L, Dai QY (2015) A novel stearic acid-modified hirudin peptidomimetic with improved pharmacokinetic properties and anticoagulant activity. Sci Rep 5(24):352\u2013366. https:\/\/doi.org\/10.1038\/srep14349","journal-title":"Sci Rep"},{"issue":"2","key":"3454_CR106","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","volume":"16","author":"YY Liu","year":"2016","unstructured":"Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, Doi Y, Tian GB, Dong BL, Huang XH, Yu LF, Gu DX, Ren HW, Chen XJ, Lv LC, He DD, Zhou HW, Liang ZS, Liu JH, Shen JZ (2016) Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16(2):161\u2013168. https:\/\/doi.org\/10.1016\/S1473-3099(15)00424-7","journal-title":"Lancet Infect Dis"},{"issue":"43","key":"3454_CR107","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ajem.2024.01.010","volume":"78","author":"BT Long","year":"2024","unstructured":"Long BT, Pelletier J, Koyfman A, Bridwell RE (2024) GLP-1 agonists: a review for emergency clinicians. Am J Emerg Med 78(43):89\u201394. https:\/\/doi.org\/10.1016\/j.ajem.2024.01.010","journal-title":"Am J Emerg Med"},{"issue":"7","key":"3454_CR108","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.3389\/fmicb.2020.563030","volume":"11","author":"JG Lu","year":"2020","unstructured":"Lu JG, Xu HJ, Xia JH, Ma J, Xu J, Li YN, Feng J (2020) D- and unnatural amino acid substituted antimicrobial peptides with improved proteolytic resistance and their proteolytic degradation characteristics. Front Microbiol 11(7):2442\u20132456. https:\/\/doi.org\/10.3389\/fmicb.2020.563030","journal-title":"Front Microbiol"},{"issue":"21","key":"3454_CR109","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.3390\/ijms222111401","volume":"22","author":"Y Luo","year":"2021","unstructured":"Luo Y, Song Y (2021) Mechanism of antimicrobial peptides: antimicrobial, anti-inflammatory and antibiofilm activities. Int J Mol Sci 22(21):1233\u20131242. https:\/\/doi.org\/10.3390\/ijms222111401","journal-title":"Int J Mol Sci"},{"issue":"12","key":"3454_CR110","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1038\/s41467-018-04255-z","volume":"9","author":"Q Luo","year":"2018","unstructured":"Luo Q, Lin YX, Yang PP, Wang Y, Qi GB, Qiao ZY, Li BN, Zhang K, Zhang JP, Wang L, Wang H (2018) A self-destructive nanosweeper that captures and clears amyloid \u03b2-peptides. Nat Commun 9(12):2552\u20132561. https:\/\/doi.org\/10.1038\/s41467-018-04255-z","journal-title":"Nat Commun"},{"issue":"45","key":"3454_CR111","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.biochi.2021.08.007","volume":"191","author":"X Luo","year":"2021","unstructured":"Luo X, Ouyang J, Wang Y, Zhang M, Fu L, Xiao N, Gao L, Zhang P, Zhou J, Wang Y (2021) A novel anionic cathelicidin lacking direct antimicrobial activity but with potent anti-inflammatory and wound healing activities from the salamander tylototriton kweichowensis. Biochimie 191(45):37\u201350. https:\/\/doi.org\/10.1016\/j.biochi.2021.08.007","journal-title":"Biochimie"},{"issue":"432","key":"3454_CR112","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1016\/j.ejmech.2021.113167","volume":"213","author":"M Maciuszek","year":"2021","unstructured":"Maciuszek M, Cacace A, Brennan E, Godson C, Chapman TM (2021) Recent advances in the design and development of formyl peptide receptor 2 (FPR2\/ALX) agonists as pro-resolving agents with diverse therapeutic potential. Eur J Med Chem 213(432):2414\u20132422. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113167","journal-title":"Eur J Med Chem"},{"issue":"14","key":"3454_CR114","doi-asserted-by":"publisher","first-page":"4819","DOI":"10.1128\/Aem.00940-15","volume":"81","author":"MA Maky","year":"2015","unstructured":"Maky MA, Ishibashi N, Zendo T, Perez RH, Doud JR, Karmi M, Sonomoto K (2015) Enterocin F4\u20139, a novel-linked glycosylated bacteriocin. Appl Environ Microb 81(14):4819\u20134826. https:\/\/doi.org\/10.1128\/Aem.00940-15","journal-title":"Appl Environ Microb"},{"issue":"8","key":"3454_CR115","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1021\/acs.orglett.0c00713","volume":"22","author":"E Masri","year":"2020","unstructured":"Masri E, Ahsanullah AM, Rademann J (2020) Side-chain modification of peptides using a phosphoranylidene amino acid. Org Lett 22(8):2976\u20132980. https:\/\/doi.org\/10.1021\/acs.orglett.0c00713","journal-title":"Org Lett"},{"issue":"23","key":"3454_CR116","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.colsurfb.2017.02.003","volume":"153","author":"P Maturana","year":"2017","unstructured":"Maturana P, Martinez M, Noguera ME, Santos NC, Disalva EA, Semorile L, Maffia PC, Hollmann A (2017) Lipid selectivity in novel antimicrobial peptides: implication on antimicrobial and hemolytic activity. Colloid Surface B 153(23):152\u2013159. https:\/\/doi.org\/10.1016\/j.colsurfb.2017.02.003","journal-title":"Colloid Surface B"},{"issue":"6","key":"3454_CR118","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1021\/acsinfecdis.9b00097","volume":"5","author":"DN McBrayer","year":"2019","unstructured":"McBrayer DN, Gantman BK, Tal-Gan Y (2019) Methylation of amino acids in gelatinase biosynthesis-activating pheromone identifies key site for stability enhancement with retention of the fsr quorum sensing circuit response. ACS Infect Dis 5(6):1035\u20131041. https:\/\/doi.org\/10.1021\/acsinfecdis.9b00097","journal-title":"ACS Infect Dis"},{"issue":"32","key":"3454_CR120","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1200\/JCO.2017.35.15_suppl.2505","volume":"35","author":"F Meric-Bernstam","year":"2017","unstructured":"Meric-Bernstam F, Saleh MN, Infante JR, Goel S, Falchook GS, Shapiro G, Chung KY, Conry RM, Hong DS, Wang JSZ, Steidl U, Walensky LD, Guerlavais V, Payton M, Annis DA, Aivado M, Patel MR (2017) Phase I trial of a novel stapled peptide ALRN-6924 disrupting MDMX- and MDM2-mediated inhibition of WT p53 in patients with solid tumors and lymphomas. J Clin Oncol 35(32):241\u2013252. https:\/\/doi.org\/10.1200\/JCO.2017.35.15_suppl.2505","journal-title":"J Clin Oncol"},{"issue":"4","key":"3454_CR121","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1021\/jacs.6b05656","volume":"256","author":"JY Miao","year":"2018","unstructured":"Miao JY, Slough D, Cummings A, Fonseca F, Kritzer J, Lin YS (2018) Designing cyclic-peptide inhibitors of protein-protein interactions by mimicking hot loops. Abstr Pap Am Chem Soc 256(4):12\u201323. https:\/\/doi.org\/10.1021\/jacs.6b05656","journal-title":"Abstr Pap Am Chem Soc"},{"issue":"4","key":"3454_CR123","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cbpa.2017.03.014","volume":"38","author":"B Mishra","year":"2017","unstructured":"Mishra B, Reiling S, Zarena D, Wang GS (2017) Host defense antimicrobial peptides as antibiotics: design and application strategies. Curr Opin Chem Biol 38(4):87\u201396. https:\/\/doi.org\/10.1016\/j.cbpa.2017.03.014","journal-title":"Curr Opin Chem Biol"},{"issue":"7","key":"3454_CR124","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.bbapap.2017.12.010","volume":"1866","author":"T Miyamoto","year":"2018","unstructured":"Miyamoto T, Homma H (2018) Detection and quantification of D-amino acid residues in peptides and proteins using acid hydrolysis. BBA-Proteins Proteom 1866(7):775\u2013782. https:\/\/doi.org\/10.1016\/j.bbapap.2017.12.010","journal-title":"BBA-Proteins Proteom"},{"issue":"1","key":"3454_CR125","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41598-020-71771-8","volume":"10","author":"N Molchanova","year":"2020","unstructured":"Molchanova N, Nielsen JE, Sorensen KB, Prabhala BK, Hansen PR, Lund R, Barron AE, Jenssen H (2020) Halogenation as a tool to tune antimicrobial activity of peptoids. Sci Rep 10(1):242\u2013256. https:\/\/doi.org\/10.1038\/s41598-020-71771-8","journal-title":"Sci Rep"},{"issue":"8","key":"3454_CR126","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1021\/acsinfecdis.1c00147","volume":"7","author":"EH Mood","year":"2021","unstructured":"Mood EH, Goltermann L, Brolin C, Cavaco LM, Nejad AJ, Yavari N, Frederiksen N, Franzyk H, Nielsen PE (2021) Antibiotic potentiation in multidrug-resistant gram-negative pathogenic bacteria by a synthetic peptidomimetic. ACS Infect Dis 7(8):2152\u20132163. https:\/\/doi.org\/10.1021\/acsinfecdis.1c00147","journal-title":"ACS Infect Dis"},{"issue":"4","key":"3454_CR127","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1039\/c5sc04392a","volume":"7","author":"SV Moradi","year":"2016","unstructured":"Moradi SV, Hussein WM, Varamini P, Simerska P, Toth I (2016) Glycosylation, an effective synthetic strategy to improve the bioavailability of therapeutic peptides. Chem Sci 7(4):2492\u20132500. https:\/\/doi.org\/10.1039\/c5sc04392a","journal-title":"Chem Sci"},{"issue":"6","key":"3454_CR129","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1128\/Aac.06335-11","volume":"56","author":"CJ Morris","year":"2012","unstructured":"Morris CJ, Beck K, Fox MA, Ulaeto D, Clark GC, Gumbleton M (2012) Pegylation of antimicrobial peptides maintains the active peptide conformation, model membrane interactions, and antimicrobial activity while improving lung tissue biocompatibility following airway delivery. Antimicrob Agents Chemother 56(6):3298\u20133308. https:\/\/doi.org\/10.1128\/Aac.06335-11","journal-title":"Antimicrob Agents Chemother"},{"issue":"17","key":"3454_CR130","doi-asserted-by":"publisher","first-page":"9500","DOI":"10.1021\/acs.jmedchem.0c00686","volume":"63","author":"CBF Mourao","year":"2020","unstructured":"Mourao CBF, Brand GD, Fernandes JPC, Prates MV, Bloch C Jr, Barbosa J, Freitas SM, Restano-Cassulini R, Possani LD, Schwartz EF (2020) Head-to-tail cyclization after interaction with trypsin: a scorpion venom peptide that resembles plant cyclotides. J Med Chem 63(17):9500\u20139511. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00686","journal-title":"J Med Chem"},{"issue":"12","key":"3454_CR131","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1001\/jama.2024.2252","volume":"331","author":"D Mozaffarian","year":"2024","unstructured":"Mozaffarian D (2024) GLP-1 agonists for obesity-a new recipe for success? JAMA-J Am Med Assoc 331(12):1007\u20131008. https:\/\/doi.org\/10.1001\/jama.2024.2252","journal-title":"JAMA-J Am Med Assoc"},{"issue":"4","key":"3454_CR132","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41573-020-00135-8","volume":"20","author":"M Muttenthaler","year":"2021","unstructured":"Muttenthaler M, King GF, Adams DJ, Alewood PF (2021) Trends in peptide drug discovery. Nat Rev Drug Discov 20(4):309\u2013325. https:\/\/doi.org\/10.1038\/s41573-020-00135-8","journal-title":"Nat Rev Drug Discov"},{"issue":"52","key":"3454_CR133","doi-asserted-by":"publisher","first-page":"26516","DOI":"10.1073\/pnas.1909585117","volume":"116","author":"J Mwangi","year":"2019","unstructured":"Mwangi J, Yin YZ, Wang G, Yang M, Li Y, Zhang ZY, Lai R (2019) The antimicrobial peptide ZY4 combats multidrug-resistant and infection. Proc Natl Acad Sci USA 116(52):26516\u201326522. https:\/\/doi.org\/10.1073\/pnas.1909585117","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"3454_CR134","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1021\/acsinfecdis.1c00101","volume":"7","author":"JL Narayana","year":"2021","unstructured":"Narayana JL, Golla R, Mishra B, Wang XQ, Lushnikova T, Zhang YX, Verma A, Kumar V, Xie JW, Wang GS (2021) Short and robust anti-infective lipopeptides engineered based on the minimal antimicrobial peptide KR12 of human LL-37. ACS Infect Dis 7(6):1795\u20131808. https:\/\/doi.org\/10.1021\/acsinfecdis.1c00101","journal-title":"ACS Infect Dis"},{"issue":"3","key":"3454_CR135","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.2174\/156802661807180709111525","volume":"22","author":"S Neukirchen","year":"2016","unstructured":"Neukirchen S, Roschger C, Els\u00e4sser B, Schubert M, Cabrele C (2016) Cyclic peptides for targeting helical protein\u2013protein interactions. J Pept Sci 22(3):S50\u2013S52. https:\/\/doi.org\/10.2174\/156802661807180709111525","journal-title":"J Pept Sci"},{"issue":"1","key":"3454_CR139","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1128\/Aac.03513-14","volume":"59","author":"AC Nilsson","year":"2015","unstructured":"Nilsson AC, Janson H, Wold H, Fugelli A, Andersson K, H\u00e2kang\u00e2rd C, Olsson P, Olsen WM (2015) LTX-109 is a novel agent for nasal decolonization of methicillin-resistant and -sensitive. Antimicrob Agents Chemother 59(1):145\u2013151. https:\/\/doi.org\/10.1128\/Aac.03513-14","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"3454_CR140","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.sbi.2016.09.003","volume":"40","author":"GE Norris","year":"2016","unstructured":"Norris GE, Patchett ML (2016) The glycocins: in a class of their own. Curr Opin Struct Biol 40(3):112\u2013119. https:\/\/doi.org\/10.1016\/j.sbi.2016.09.003","journal-title":"Curr Opin Struct Biol"},{"issue":"8","key":"3454_CR141","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1080\/17460441.2024.2365969","volume":"19","author":"L Otvos","year":"2024","unstructured":"Otvos L (2024) The latest trends in peptide drug discovery and future challenges. Expert Opin Drug Discov 19(8):869\u2013872. https:\/\/doi.org\/10.1080\/17460441.2024.2365969","journal-title":"Expert Opin Drug Discov"},{"issue":"11","key":"3454_CR142","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202200944","volume":"11","author":"M Pan","year":"2022","unstructured":"Pan M, Lu C, Zheng M, Zhou W, Song F, Chen W, Yao F, Liu D, Cai J (2022) Unnatural amino-acid-based star-shaped poly(L-ornithine)s as emerging long-term and biofilm-disrupting antimicrobial peptides to treat pseudomonas aeruginosa-infected burn wounds. Adv Healthc Mater 11(11):e2200944. https:\/\/doi.org\/10.1002\/adhm.202200944","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"3454_CR143","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41598-021-01750-0","volume":"11","author":"S Pechenov","year":"2021","unstructured":"Pechenov S, Revell J, Will S, Naylor J, Tyagi P, Patel C, Liang LH, Tseng L, Huang Y, Rosenbaum AI, Balic K, Konkar A, Grimsby J, Subramony JA (2021) Development of an orally delivered GLP-1 receptor agonist through peptide engineering and drug delivery to treat chronic disease. Sci Rep 11(1):124\u2013133. https:\/\/doi.org\/10.1038\/s41598-021-01750-0","journal-title":"Sci Rep"},{"issue":"40","key":"3454_CR145","doi-asserted-by":"publisher","first-page":"24903","DOI":"10.1039\/c7ra02706k","volume":"7","author":"KM Peng","year":"2017","unstructured":"Peng KM, Zou T, Ding W, Wang RN, Guo JS, Round JJ, Tu WP, Liu C, Hu JQ (2017) Development of contact-killing non-leaching antimicrobial guanidyl-functionalized polymers click chemistry. Rsc Adv 7(40):24903\u201324913. https:\/\/doi.org\/10.1039\/c7ra02706k","journal-title":"Rsc Adv"},{"issue":"3","key":"3454_CR146","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1039\/c7ob02952g","volume":"16","author":"SR Perry","year":"2018","unstructured":"Perry SR, Hill TA, de Araujo AD, Hoang HN, Fairlie DP (2018) Contiguous hydrophobic and charged surface patches in short helix-constrained peptides drive cell permeability. Org Biomol Chem 16(3):367\u2013371. https:\/\/doi.org\/10.1039\/c7ob02952g","journal-title":"Org Biomol Chem"},{"issue":"88","key":"3454_CR148","doi-asserted-by":"publisher","first-page":"11578","DOI":"10.1039\/d1cc03793e","volume":"57","author":"SB Rezende","year":"2021","unstructured":"Rezende SB, Oshiro KGN, J\u00fanior NGO, Franco OL, Cardoso MH (2021) Advances on chemically modified antimicrobial peptides for generating peptide antibiotics. Chem Commun 57(88):11578\u201311590. https:\/\/doi.org\/10.1039\/d1cc03793e","journal-title":"Chem Commun"},{"issue":"18","key":"3454_CR149","doi-asserted-by":"publisher","first-page":"7307","DOI":"10.1021\/acs.orglett.9b02592","volume":"21","author":"MG Ricardo","year":"2019","unstructured":"Ricardo MG, Vasco AV, Rivera DG, Wessjohann LA (2019) Stabilization of cyclic \u03b2-hairpins by ugi-reaction-derived-alkylated peptides: the quest for functionalized \u03b2-turns. Org Lett 21(18):7307\u20137310. https:\/\/doi.org\/10.1021\/acs.orglett.9b02592","journal-title":"Org Lett"},{"issue":"13","key":"3454_CR150","doi-asserted-by":"publisher","first-page":"5235","DOI":"10.1002\/anie.201916257","volume":"59","author":"MG Ricardo","year":"2020","unstructured":"Ricardo MG, Ali AM, Plewka J, Surmiak E, Labuzek B, Neochoritis CG, Atmaj J, Skalniak L, Zhang R, Holak TA, Groves M, Rivera DG, D\u00f6mling A (2020) Multicomponent peptide stapling as a diversity-driven tool for the development of inhibitors of protein\u2013protein interactions. Angew Chem Int Ed 59(13):5235\u20135241. https:\/\/doi.org\/10.1002\/anie.201916257","journal-title":"Angew Chem Int Ed"},{"issue":"4","key":"3454_CR151","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/bip.22624","volume":"104","author":"Z Ridgway","year":"2015","unstructured":"Ridgway Z, Picciano AL, Gosavi PM, Moroz YS, Angevine CE, Chavis AE, Reiner JE, Korendovych IV, Caputo GA (2015) Functional characterization of a melittin analog containing a non-natural tryptophan analog. Biopolymers 104(4):384\u2013394. https:\/\/doi.org\/10.1002\/bip.22624","journal-title":"Biopolymers"},{"issue":"43","key":"3454_CR153","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.abb.2015.05.018","volume":"579","author":"B Rizzuti","year":"2015","unstructured":"Rizzuti B, Bartucci R, Sportelli L, Guzzi R (2015) Fatty acid binding into the highest affinity site of human serum albumin observed in molecular dynamics simulation. Arch Biochem Biophys 579(43):18\u201325. https:\/\/doi.org\/10.1016\/j.abb.2015.05.018","journal-title":"Arch Biochem Biophys"},{"issue":"42","key":"3454_CR154","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.addr.2012.09.025","volume":"64","author":"MJ Roberts","year":"2012","unstructured":"Roberts MJ, Bentley MD, Harris JM (2012) Chemistry for peptide and protein PEGylation. Adv Drug Deliv Rev 64(42):116\u2013127. https:\/\/doi.org\/10.1016\/j.addr.2012.09.025","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"3454_CR155","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3389\/fphar.2024.1363139","volume":"15","author":"BJ Roberts","year":"2024","unstructured":"Roberts BJ, Mattei AE, Howard KE, Weaver JL, Liu H, Lelias S, Martin WD, Verthelyi D, Pang ER, Edwards KJ, De Groot AS (2024) Assessing the immunogenicity risk of salmon calcitonin peptide impurities using and methods. Front Pharmacol 15(3):232\u2013243. https:\/\/doi.org\/10.3389\/fphar.2024.1363139","journal-title":"Front Pharmacol"},{"issue":"24","key":"3454_CR156","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3390\/ijms21249692","volume":"21","author":"T Rounds","year":"2020","unstructured":"Rounds T, Straus SK (2020) Lipidation of antimicrobial peptides as a design strategy for future alternatives to antibiotics. Int J Mol Sci 21(24):214\u2013232. https:\/\/doi.org\/10.3390\/ijms21249692","journal-title":"Int J Mol Sci"},{"issue":"8","key":"3454_CR157","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1128\/Aac.48.8.3112-3118.2004","volume":"48","author":"HS Sader","year":"2004","unstructured":"Sader HS, Fedler KA, Rennie RP, Stevens S, Jones RN (2004) Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: spectrum of antimicrobial activity and measurements of bactericidal activity. Antimicrob Agents Chemother 48(8):3112\u20133118. https:\/\/doi.org\/10.1128\/Aac.48.8.3112-3118.2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"19","key":"3454_CR158","doi-asserted-by":"publisher","first-page":"5236","DOI":"10.1158\/1078-0432.Ccr-21-0715","volume":"27","author":"MN Saleh","year":"2021","unstructured":"Saleh MN, Patel MR, Bauer TM, Goel S, Falchook GS, Shapiro GI, Chung KY, Infante JR, Conry RM, Rabinowits G, Hong DS, Wang JS, Steidl U, Naik G, Guerlavais V, Vukovic V, Annis DA, Aivado M, Meric-Bernstam F (2021) Phase 1 trial of ALRN-6924, a dual inhibitor of MDMX and MDM2, in patients with solid tumors and lymphomas bearing wild-type. Clin Cancer Res 27(19):5236\u20135247. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-21-0715","journal-title":"Clin Cancer Res"},{"issue":"12","key":"3454_CR159","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/biom12121841","volume":"12","author":"B Sana","year":"2022","unstructured":"Sana B, Ke D, Li EHY, Ho TMY, Seayad J, Duong HA, Ghadessy FJ (2022) Halogenation of peptides and proteins using engineered tryptophan halogenase enzymes. Biomolecules 12(12):12\u201323. https:\/\/doi.org\/10.3390\/biom12121841","journal-title":"Biomolecules"},{"issue":"23","key":"3454_CR161","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.peptides.2019.170180","volume":"123","author":"MN Savitha","year":"2020","unstructured":"Savitha MN, Suvilesh KN, Siddesha JM, Gowda MDM, Choudhury M, Velmurugan D, Umashankar M, Vishwanath BS (2020) Combinatorial inhibition of angiotensin converting enzyme, neutral endopeptidase and aminopeptidase N by methylated peptides alleviates blood pressure and fibrosis in rat model of dexamethasone-induced hypertension. Peptides 123(23):442\u2013453. https:\/\/doi.org\/10.1016\/j.peptides.2019.170180","journal-title":"Peptides"},{"issue":"3","key":"3454_CR162","first-page":"146","volume":"79","author":"A Scheen","year":"2024","unstructured":"Scheen A (2024) GLP-1 receptor agonists in type 2 diabetes: paradoxical real-life underuse in patients with atherosclerotic cardiovascular disease. Rev Med Liege 79(3):146\u2013151","journal-title":"Rev Med Liege"},{"issue":"4","key":"3454_CR164","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s11274-018-2444-5","volume":"34","author":"N Shagaghi","year":"2018","unstructured":"Shagaghi N, Palombo EA, Clayton AHA, Bhave M (2018) Antimicrobial peptides: biochemical determinants of activity and biophysical techniques of elucidating their functionality. World J Microb Biot 34(4):242\u2013255. https:\/\/doi.org\/10.1007\/s11274-018-2444-5","journal-title":"World J Microb Biot"},{"issue":"4","key":"3454_CR165","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1208\/s12248-014-9599-2","volume":"16","author":"G Shankar","year":"2014","unstructured":"Shankar G, Arkin S, Cocea L, Devanarayan V, Kirshner S, Kromminga A, Quarmby V, Richards S, Schneider CK, Subramanyam M, Swanson S, Verthelyi D, Yim S (2014) Assessment and reporting of the clinical immunogenicity of therapeutic proteins and peptides-harmonized terminology and tactical recommendations. AAPS J 16(4):658\u2013673. https:\/\/doi.org\/10.1208\/s12248-014-9599-2","journal-title":"AAPS J"},{"issue":"16","key":"3454_CR166","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.4155\/fmc-2019-0167","volume":"11","author":"C Shao","year":"2019","unstructured":"Shao C, Zhu Y, Lai Z, Tan P, Shan A (2019) Antimicrobial peptides with protease stability: progress and perspective. Future Med Chem 11(16):2047\u20132050. https:\/\/doi.org\/10.4155\/fmc-2019-0167","journal-title":"Future Med Chem"},{"issue":"34","key":"3454_CR167","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1182\/blood-2018-99-119489","volume":"132","author":"AR Shustov","year":"2018","unstructured":"Shustov AR, Mehta A, Sokol L, Carvajal LA, Guerlavais V, Samant M, Narasimhan N, Sutton D, Annis DA, Pinchasik D, Aivado M, Korn R (2018) Pseudoprogression (PsP) in patients with peripheral T-cell lymphoma (PTCL) treated with the novel stapled peptide ALRN-6924, a dual inhibitor of MDMX and MDM2. Blood 132(34):241\u2013252. https:\/\/doi.org\/10.1182\/blood-2018-99-119489","journal-title":"Blood"},{"issue":"4","key":"3454_CR169","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1021\/bm401884e","volume":"15","author":"S Singh","year":"2014","unstructured":"Singh S, Papareddy P, M\u00f6rgelin M, Schmidtchen A, Malmsten M (2014) Effects of PEGylation on membrane and lipopolysaccharide interactions of host defense peptides. Biomacromol 15(4):1337\u20131345. https:\/\/doi.org\/10.1021\/bm401884e","journal-title":"Biomacromol"},{"issue":"3","key":"3454_CR170","doi-asserted-by":"publisher","first-page":"764","DOI":"10.3390\/ph3030764","volume":"3","author":"A Sjoholm","year":"2010","unstructured":"Sjoholm A (2010) Liraglutide therapy for type 2 diabetes: overcoming unmet needs. Pharmaceuticals 3(3):764\u2013781. https:\/\/doi.org\/10.3390\/ph3030764","journal-title":"Pharmaceuticals"},{"issue":"3","key":"3454_CR171","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202400512","volume":"234","author":"Y Song","year":"2024","unstructured":"Song Y, Lei L, Cai X, Wei H, Yu CY (2024) Immunomodulatory peptides for tumor treatment. Adv Healthc Mater 234(3):e2400512. https:\/\/doi.org\/10.1002\/adhm.202400512","journal-title":"Adv Healthc Mater"},{"issue":"29","key":"3454_CR172","doi-asserted-by":"publisher","first-page":"8415","DOI":"10.1002\/slct.201800855","volume":"3","author":"SF Sousa","year":"2018","unstructured":"Sousa SF, Peres J, Coelho M, Vieira TF (2018) Analyzing PEGylation through molecular dynamics simulations. ChemistrySelect 3(29):8415\u20138427. https:\/\/doi.org\/10.1002\/slct.201800855","journal-title":"ChemistrySelect"},{"issue":"13","key":"3454_CR173","doi-asserted-by":"publisher","first-page":"6276","DOI":"10.1021\/acs.jmedchem.9b00657","volume":"62","author":"TA Stone","year":"2019","unstructured":"Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM (2019) Positive charge patterning and hydrophobicity of membrane-active antimicrobial peptides as determinants of activity, toxicity, and pharmacokinetic stability. J Med Chem 62(13):6276\u20136286. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b00657","journal-title":"J Med Chem"},{"issue":"3","key":"3454_CR174","doi-asserted-by":"publisher","first-page":"184260","DOI":"10.1016\/j.bbamem.2023.184260","volume":"1866","author":"SK Straus","year":"2024","unstructured":"Straus SK (2024) Tryptophan- and arginine-rich antimicrobial peptides: anti-infectives with great potential. Biochim Biophys Acta Biomembr 1866(3):184260\u2013184276. https:\/\/doi.org\/10.1016\/j.bbamem.2023.184260","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"25","key":"3454_CR175","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1039\/c7py00528h","volume":"8","author":"YJ Su","year":"2017","unstructured":"Su YJ, Tian L, Yu M, Gao Q, Wang DH, Xi YW, Yang P, Lei B, Ma PX, Li P (2017) Cationic peptidopolysaccharides synthesized by \u2018click\u2019 chemistry with enhanced broad-spectrum antimicrobial activities. Polym Chem 8(25):3788\u20133800. https:\/\/doi.org\/10.1039\/c7py00528h","journal-title":"Polym Chem"},{"key":"3454_CR177","first-page":"V","volume":"1030","author":"A Sunna","year":"2017","unstructured":"Sunna A, Care A, Bergquist PL (2017) Peptides and peptide-based biomaterials and their biomedical applications preface. Adv Exp Med Biol 1030:V\u2013Ix","journal-title":"Adv Exp Med Biol"},{"issue":"32","key":"3454_CR178","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jconrel.2021.01.015","volume":"331","author":"M Sylvestre","year":"2021","unstructured":"Sylvestre M, Lv SX, Yang LF, Luera N, Peeler DJ, Chen BM, Roffler SR, Pun SH (2021) Replacement of L-amino acid peptides with D-amino acid peptides mitigates anti-PEG antibody generation against polymer-peptide conjugates in mice. J Control Release 331(32):142\u2013153. https:\/\/doi.org\/10.1016\/j.jconrel.2021.01.015","journal-title":"J Control Release"},{"issue":"26","key":"3454_CR179","doi-asserted-by":"publisher","first-page":"5641","DOI":"10.1002\/ejoc.201402238","volume":"2014","author":"T Szekely","year":"2014","unstructured":"Szekely T, Roy O, Faure S, Taillefumier C (2014) From glycopeptides to glycopeptoids. Eur J Org Chem 2014(26):5641\u20135657. https:\/\/doi.org\/10.1002\/ejoc.201402238","journal-title":"Eur J Org Chem"},{"issue":"32","key":"3454_CR180","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ijbiomac.2022.07.103","volume":"218","author":"A Thakur","year":"2022","unstructured":"Thakur A, Sharma A, Alajangi HK, Jaiswal PK, Lim YB, Singh G, Barnwal RP (2022) In pursuit of next-generation therapeutics: antimicrobial peptides against superbugs, their sources, mechanism of action, nanotechnology-based delivery, and clinical applications. Int J Biol Macromol 218(32):135\u2013156. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.07.103","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"3454_CR181","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1615\/critrevtherdrugcarriersyst.2022040322","volume":"40","author":"R Thakur","year":"2023","unstructured":"Thakur R, Suri CR, Kaur IP, Rishi P (2023) Peptides as diagnostic, therapeutic, and theranostic tools: progress and future challenges. Crit Rev Ther Drug 40(1):49\u2013100. https:\/\/doi.org\/10.1615\/critrevtherdrugcarriersyst.2022040322","journal-title":"Crit Rev Ther Drug"},{"issue":"21","key":"3454_CR182","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1002\/cbic.201700352","volume":"18","author":"Y Tian","year":"2017","unstructured":"Tian Y, Jiang Y, Li J, Wang D, Zhao H, Li Z (2017) Effect of stapling architecture on physiochemical properties and cell permeability of stapled alpha-helical peptides: a comparative study. Chembiochem: Eur J Chem Biol 18(21):2087\u20132093. https:\/\/doi.org\/10.1002\/cbic.201700352","journal-title":"Chembiochem: Eur J Chem Biol"},{"issue":"3","key":"3454_CR183","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3389\/fimmu.2020.00983","volume":"11","author":"DSJ Ting","year":"2020","unstructured":"Ting DSJ, Beuerman RW, Dua HS, Lakshminarayanan R, Mohammed I (2020) Strategies in translating the therapeutic potentials of host defense peptides. Front Immunol 11(3):874\u2013886. https:\/\/doi.org\/10.3389\/fimmu.2020.00983","journal-title":"Front Immunol"},{"issue":"32","key":"3454_CR184","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cis.2017.06.001","volume":"247","author":"OG Travkova","year":"2017","unstructured":"Travkova OG, Moehwald H, Brezesinski G (2017) The interaction of antimicrobial peptides with membranes. Adv Colloid Interface 247(32):521\u2013532. https:\/\/doi.org\/10.1016\/j.cis.2017.06.001","journal-title":"Adv Colloid Interface"},{"issue":"31","key":"3454_CR185","doi-asserted-by":"publisher","first-page":"9585","DOI":"10.1002\/chem.201001642","volume":"16","author":"G Triola","year":"2010","unstructured":"Triola G, Gerauer M, G\u00f6rmer K, Brunsveld L, Waldmann H (2010) Solid-phase synthesis of lipidated Ras peptides employing the Ellman sulfonamide linker. Chem Eur J 16(31):9585\u20139591. https:\/\/doi.org\/10.1002\/chem.201001642","journal-title":"Chem Eur J"},{"issue":"3","key":"3454_CR186","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/S0360-3016(03)01627-4","volume":"58","author":"A Trotti","year":"2004","unstructured":"Trotti A, Garden A, Warde P, Symonds P, Langer C, Redman R, Pajak TF, Fleming TR, Henke M, Bourhis J, Rosenthal DI, Junor E, Cmelak A, Sheehan F, Pulliam J, Devitt-Risse P, Fuchs H, Chambers M, O\u2019Sullivan B, Ang KK (2004) A multinational, randomized phase III trial of iseganan HCL oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy. Int J Radiat Oncol 58(3):674\u2013681. https:\/\/doi.org\/10.1016\/S0360-3016(03)01627-4","journal-title":"Int J Radiat Oncol"},{"issue":"2","key":"3454_CR187","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/pep2.24326","volume":"116","author":"S Ullrich","year":"2024","unstructured":"Ullrich S, Nitsche C (2024) Bicyclic peptides: paving the road for therapeutics of the future. Pept Sci 116(2):242\u2013253. https:\/\/doi.org\/10.1002\/pep2.24326","journal-title":"Pept Sci"},{"issue":"19","key":"3454_CR188","doi-asserted-by":"publisher","first-page":"11342","DOI":"10.1073\/pnas.95.19.11342","volume":"95","author":"S Uttenweiler-Joseph","year":"1998","unstructured":"Uttenweiler-Joseph S, Moniatte M, Lagueux M, Van Dorsselaer A, Hoffmann JA, Bulet P (1998) Differential display of peptides induced during the immune response of: a matrix-assisted laser desorption ionization time-of-flight mass spectrometry study. Proc Natl Acad Sci USA 95(19):11342\u201311347. https:\/\/doi.org\/10.1073\/pnas.95.19.11342","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"3454_CR191","doi-asserted-by":"publisher","first-page":"4167","DOI":"10.1021\/jacs.8b13178","volume":"141","author":"AA Vinogradov","year":"2019","unstructured":"Vinogradov AA, Yin YZ, Suga H (2019) Macrocyclic peptides as drug candidates: recent progress and remaining challenges. J Am Chem Soc 141(10):4167\u20134181. https:\/\/doi.org\/10.1021\/jacs.8b13178","journal-title":"J Am Chem Soc"},{"issue":"1","key":"3454_CR192","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2174\/2211550111201010072","volume":"1","author":"G Wang","year":"2012","unstructured":"Wang G (2012) Post-translational modifications of natural antimicrobial peptides and strategies for peptide engineering. Curr Biotechnol 1(1):72\u201379. https:\/\/doi.org\/10.2174\/2211550111201010072","journal-title":"Curr Biotechnol"},{"issue":"13","key":"3454_CR194","doi-asserted-by":"publisher","first-page":"6224","DOI":"10.1021\/jm300664y","volume":"55","author":"Y Wang","year":"2012","unstructured":"Wang Y, Xing YH, Liu X, Ji H, Kai M, Chen ZY, Yu J, Zhao DP, Ren H, Wang R (2012) A new class of highly potent and selective endomorphin-1 analogues containing \u03b1-methylene-\u03b2-aminopropanoic acids (map). J Med Chem 55(13):6224\u20136236. https:\/\/doi.org\/10.1021\/jm300664y","journal-title":"J Med Chem"},{"issue":"1","key":"3454_CR195","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1021\/ja411159k","volume":"136","author":"H Wang","year":"2014","unstructured":"Wang H, Oman TJ, Zhang R, De Gonzalo CVG, Zhang Q, van der Donk WA (2014) The glycosyltransferase involved in thurandacin biosynthesis catalyzes both O- and S-glycosylation. J Am Chem Soc 136(1):84\u201387. https:\/\/doi.org\/10.1021\/ja411159k","journal-title":"J Am Chem Soc"},{"issue":"3","key":"3454_CR196","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/med.21542","volume":"39","author":"JJ Wang","year":"2019","unstructured":"Wang JJ, Dou XJ, Song J, Lyu YF, Zhu X, Xu L, Li WZ, Shan AS (2019) Antimicrobial peptides: promising alternatives in the post feeding antibiotic era. Med Res Rev 39(3):831\u2013859. https:\/\/doi.org\/10.1002\/med.21542","journal-title":"Med Res Rev"},{"issue":"1","key":"3454_CR197","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","volume":"7","author":"L Wang","year":"2022","unstructured":"Wang L, Wang N, Zhang W, Cheng X, Yan Z, Shao G, Wang X, Wang R, Fu C (2022) Therapeutic peptides: current applications and future directions. Signal Transduct Target Ther 7(1):48\u201356. https:\/\/doi.org\/10.1038\/s41392-022-00904-4","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"3454_CR199","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nchem.1062","volume":"3","author":"CJ White","year":"2011","unstructured":"White CJ, Yudin AK (2011) Contemporary strategies for peptide macrocyclization. Nat Chem 3(7):509\u2013524. https:\/\/doi.org\/10.1038\/nchem.1062","journal-title":"Nat Chem"},{"issue":"6","key":"3454_CR200","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41429-023-00615-0","volume":"76","author":"B Whitehead","year":"2023","unstructured":"Whitehead B, Antennuci F, Boysen AT, Nejsum P (2023) Polymyxin B inhibits pro-inflammatory effects of outer membrane vesicles whilst increasing immune cell uptake and clearance. J Antibiot 76(6):360\u2013364. https:\/\/doi.org\/10.1038\/s41429-023-00615-0","journal-title":"J Antibiot"},{"issue":"32","key":"3454_CR203","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1016\/j.cclet.2019.10.013","volume":"8","author":"M Wu","year":"2019","unstructured":"Wu M, Chen Q, Wang Y, Li Y, Zhao X, Chang Q (2019) Structural modification and antitumor activity of antimicrobial peptide HYL. Chin Chem Lett 8(32):2134\u20132145. https:\/\/doi.org\/10.1016\/j.cclet.2019.10.013","journal-title":"Chin Chem Lett"},{"issue":"10","key":"3454_CR204","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1021\/acs.bioconjchem.0c00355","volume":"31","author":"MH Wu","year":"2020","unstructured":"Wu MH, Ai S, Chen Q, Chen XY, Li HJ, Li YL, Zhao X (2020) Effects of glycosylation and D-amino acid substitution on the antitumor and antibacterial activities of bee venom peptide HYL. Bioconjug Chem 31(10):2293\u20132302. https:\/\/doi.org\/10.1021\/acs.bioconjchem.0c00355","journal-title":"Bioconjug Chem"},{"issue":"21","key":"3454_CR205","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.peptides.2017.05.010","volume":"94","author":"N Xiang","year":"2017","unstructured":"Xiang N, Lyu Y, Zhu X, Bhunia AK, Narsimhan G (2017) Effect of physicochemical properties of peptides from soy protein on their antimicrobial activity. Peptides 94(21):10\u201318. https:\/\/doi.org\/10.1016\/j.peptides.2017.05.010","journal-title":"Peptides"},{"issue":"7","key":"3454_CR206","doi-asserted-by":"publisher","first-page":"3218","DOI":"10.1021\/acs.jmedchem.7b00768","volume":"61","author":"PY Yang","year":"2018","unstructured":"Yang PY, Zou HF, Lee C, Muppidi A, Chao E, Fu QW, Luo XZ, Wang DL, Schultz PG, Shen WJ (2018) Stapled, long-acting glucagon-like peptide 2 analog with efficacy in dextran sodium sulfate induced mouse colitis models. J Med Chem 61(7):3218\u20133223. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b00768","journal-title":"J Med Chem"},{"issue":"12","key":"3454_CR207","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1002\/1873-3468.13444","volume":"593","author":"W Yang","year":"2019","unstructured":"Yang W, Zhang Q, Zhang CS, Guo AN, Wang YY, You HT, Zhang XL, Lai LH (2019) Computational design and optimization of novel D-peptide TNF\u03b1 inhibitors. FEBS Lett 593(12):1292\u20131302. https:\/\/doi.org\/10.1002\/1873-3468.13444","journal-title":"FEBS Lett"},{"issue":"5","key":"3454_CR209","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/jccs.200900140","volume":"56","author":"BS Yip","year":"2009","unstructured":"Yip BS, Chen HL, Cheng HT, Wu JM, Cheng JW (2009) Solution structure and model membrane interactions of P-113, a clinically active antimicrobial peptide derived from human saliva. J Chin Chem Soc 56(5):961\u2013966. https:\/\/doi.org\/10.1002\/jccs.200900140","journal-title":"J Chin Chem Soc"},{"issue":"42","key":"3454_CR210","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/nyas.12005","volume":"1277","author":"NY Yount","year":"2013","unstructured":"Yount NY, Yeaman MR (2013) Peptide antimicrobials: cell wall as a bacterial target. Ann NY Acad Sci 1277(42):127\u2013138. https:\/\/doi.org\/10.1111\/nyas.12005","journal-title":"Ann NY Acad Sci"},{"issue":"15","key":"3454_CR211","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.1016\/j.cell.2024.06.031","volume":"187","author":"JTY Yue","year":"2024","unstructured":"Yue JTY, Garrido AN, Lam TKT (2024) A metabolic balance of GLP-1 and NMDA receptors in the brain. Cell 187(15):3854\u20133856. https:\/\/doi.org\/10.1016\/j.cell.2024.06.031","journal-title":"Cell"},{"issue":"11","key":"3454_CR212","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.2174\/092986712799945003","volume":"19","author":"L Zhang","year":"2012","unstructured":"Zhang L, Bulaj G (2012) Converting peptides into drug leads by lipidation. Curr Med Chem 19(11):1602\u20131618. https:\/\/doi.org\/10.2174\/092986712799945003","journal-title":"Curr Med Chem"},{"issue":"4","key":"3454_CR213","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10989-008-9148-x","volume":"14","author":"S Zhang","year":"2008","unstructured":"Zhang S, Lin F, Hossain MA, Shabanpoor F, Tregear GW, Wade JD (2008) Simultaneous post-cysteine (S-Acm) group removal quenching of iodine and isolation of peptide by one step ether precipitation. Int J Pept Res Ther 14(4):301\u2013305. https:\/\/doi.org\/10.1007\/s10989-008-9148-x","journal-title":"Int J Pept Res Ther"},{"issue":"31","key":"3454_CR214","doi-asserted-by":"publisher","first-page":"12274","DOI":"10.1021\/jacs.9b03623","volume":"141","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Zhang Q, Wong CTT, Li X (2019) Chemoselective peptide cyclization and bicyclization directly on unprotected peptides. J Am Chem Soc 141(31):12274\u201312279. https:\/\/doi.org\/10.1021\/jacs.9b03623","journal-title":"J Am Chem Soc"},{"issue":"1","key":"3454_CR215","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40779-021-00343-2","volume":"8","author":"QY Zhang","year":"2021","unstructured":"Zhang QY, Yan ZB, Meng YM, Hong XY, Shao G, Ma JJ, Cheng XR, Liu J, Kang J, Fu CY (2021) Antimicrobial peptides: mechanism of action, activity and clinical potential. Mil Med Res 8(1):48\u201357. https:\/\/doi.org\/10.1186\/s40779-021-00343-2","journal-title":"Mil Med Res"},{"issue":"9","key":"3454_CR216","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1016\/j.apsb.2024.05.013","volume":"14","author":"X Zhang","year":"2024","unstructured":"Zhang X, Wu Y, Lin J, Lu S, Lu X, Cheng A, Chen H, Zhang W, Luan X (2024) Insights into therapeutic peptides in the cancer-immunity cycle: update and challenges. Acta Pharm Sin B 14(9):3818\u20133833. https:\/\/doi.org\/10.1016\/j.apsb.2024.05.013","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"3454_CR217","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13568-016-0295-8","volume":"6","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Zhang M, Qiu S, Wang J, Peng J, Zhao P, Zhu R, Wang H, Li Y, Wang K, Yan W, Wang R (2016) Antimicrobial activity and stability of the d-amino acid substituted derivatives of antimicrobial peptide polybia-MPI. AMB Express 6(1):122\u2013134. https:\/\/doi.org\/10.1186\/s13568-016-0295-8","journal-title":"AMB Express"},{"issue":"4","key":"3454_CR218","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.ejps.2019.105123","volume":"141","author":"C Zhong","year":"2020","unstructured":"Zhong C, Zhu NY, Zhu YW, Liu TQ, Gou SH, Xie JQ, Yao J, Ni JM (2020) Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria. Eur J Pharm Sci 141(4):242\u2013249. https:\/\/doi.org\/10.1016\/j.ejps.2019.105123","journal-title":"Eur J Pharm Sci"},{"issue":"35","key":"3454_CR219","doi-asserted-by":"publisher","first-page":"15114","DOI":"10.1002\/anie.202002783","volume":"59","author":"XM Zhou","year":"2020","unstructured":"Zhou XM, Zuo C, Li WQ, Shi WW, Zhou XW, Wang HF, Chen SM, Du JF, Chen GY, Zhai WJ, Zhao WS, Wu YH, Qi YM, Liu L, Gao YF (2020) A novel D-peptide identified by mirror-image phage display blocks TIGIT\/PVR for cancer immunotherapy. Angew Chem Int Ed 59(35):15114\u201315118. https:\/\/doi.org\/10.1002\/anie.202002783","journal-title":"Angew Chem Int Ed"},{"issue":"23","key":"3454_CR220","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.actbio.2022.09.028","volume":"153","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Akhtar MU, Li B, Chou S, Shao C, Li J, Shan A (2022) The design of cell-selective tryptophan and arginine-rich antimicrobial peptides by introducing hydrophilic uncharged residues. Acta Biomater 153(23):557\u2013572. https:\/\/doi.org\/10.1016\/j.actbio.2022.09.028","journal-title":"Acta Biomater"},{"issue":"45","key":"3454_CR221","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cbpa.2017.02.006","volume":"38","author":"A Zorzi","year":"2017","unstructured":"Zorzi A, Deyle K, Heinis C (2017) Cyclic peptide therapeutics: past, present and future. Curr Opin Chem Biol 38(45):24\u201329. https:\/\/doi.org\/10.1016\/j.cbpa.2017.02.006","journal-title":"Curr Opin Chem Biol"},{"issue":"7","key":"3454_CR222","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/psc.2774","volume":"21","author":"Y Zou","year":"2015","unstructured":"Zou Y, Zhao QJ, Zhang CM, Wang L, Li WJ, Li X, Wu QY, Hu HG (2015) Synthesis and antibacterial activities of novel tyrocidine a glycosylated derivatives towards multidrug-resistant pathogens. J Pept Sci 21(7):586\u2013592. https:\/\/doi.org\/10.1002\/psc.2774","journal-title":"J Pept Sci"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-025-03454-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00726-025-03454-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-025-03454-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T07:01:37Z","timestamp":1766473297000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00726-025-03454-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":182,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3454"],"URL":"https:\/\/doi.org\/10.1007\/s00726-025-03454-5","relation":{},"ISSN":["1438-2199"],"issn-type":[{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,8]]},"assertion":[{"value":"15 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no competing interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"25"}}